These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29132268)

  • 1. Simplifying Logistics and Avoiding the Unnecessary in Patients With Breast Cancer Undergoing Sentinel Node Biopsy. A Prospective Feasibility Trial of the Preoperative Injection of Super Paramagnetic Iron Oxide Nanoparticles.
    Karakatsanis A; Olofsson H; Stålberg P; Bergkvist L; Abdsaleh S; Wärnberg F
    Scand J Surg; 2018 Jun; 107(2):130-137. PubMed ID: 29132268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy after sentinel lymph node biopsy for early stage breast cancer using a magnetic tracer: Results of a single institutional prospective study of tolerance.
    Bazire L; Alran S; El Bamrani S; Gaujal L; Vincent-Salomon A; Tardivon A; Kirova YM
    Cancer Radiother; 2019 Feb; 23(1):23-27. PubMed ID: 30553652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.
    Karakatsanis A; Christiansen PM; Fischer L; Hedin C; Pistioli L; Sund M; Rasmussen NR; Jørnsgård H; Tegnelius D; Eriksson S; Daskalakis K; Wärnberg F; Markopoulos CJ; Bergkvist L
    Breast Cancer Res Treat; 2016 Jun; 157(2):281-294. PubMed ID: 27117158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer.
    Karakatsanis A; Daskalakis K; Stålberg P; Olofsson H; Andersson Y; Eriksson S; Bergkvist L; Wärnberg F
    Br J Surg; 2017 Nov; 104(12):1675-1685. PubMed ID: 28877348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery.
    Hersi AF; Eriksson S; Ramos J; Abdsaleh S; Wärnberg F; Karakatsanis A
    Eur J Surg Oncol; 2019 Apr; 45(4):544-549. PubMed ID: 30401506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study).
    Karakatsanis A; Hersi AF; Pistiolis L; Olofsson Bagge R; Lykoudis PM; Eriksson S; Wärnberg F;
    Br J Surg; 2019 May; 106(6):720-728. PubMed ID: 30839104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter clinical trial on sentinel lymph node biopsy using superparamagnetic iron oxide nanoparticles and a novel handheld magnetic probe.
    Taruno K; Kurita T; Kuwahata A; Yanagihara K; Enokido K; Katayose Y; Nakamura S; Takei H; Sekino M; Kusakabe M
    J Surg Oncol; 2019 Dec; 120(8):1391-1396. PubMed ID: 31667855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
    Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
    Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer.
    Rubio IT; Diaz-Botero S; Esgueva A; Rodriguez R; Cortadellas T; Cordoba O; Espinosa-Bravo M
    Eur J Surg Oncol; 2015 Jan; 41(1):46-51. PubMed ID: 25466980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial.
    Houpeau JL; Chauvet MP; Guillemin F; Bendavid-Athias C; Charitansky H; Kramar A; Giard S
    J Surg Oncol; 2016 Apr; 113(5):501-7. PubMed ID: 26754343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioguided occult lesion localization (ROLL) for treatment and diagnosis of malignant and premalignant breast lesions combined with sentinel node biopsy: a prospective clinical trial with 100 patients.
    Sarlos D; Frey LD; Haueisen H; Landmann G; Kots LA; Schaer G
    Eur J Surg Oncol; 2009 Apr; 35(4):403-8. PubMed ID: 18692358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol.
    Pouw JJ; Grootendorst MR; Bezooijen R; Klazen CA; De Bruin WI; Klaase JM; Hall-Craggs MA; Douek M; Ten Haken B
    Br J Radiol; 2015; 88(1056):20150634. PubMed ID: 26492466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the sentinel node using a magnetic tracer in thyroid cancer. A technical pilot study.
    Ríos A; Rodríguez JM; Ibañez N; Piñero A; Parrilla P
    Cir Esp (Engl Ed); 2019 Mar; 97(3):169-174. PubMed ID: 30771997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance lymphography of sentinel lymph nodes in patients with breast cancer using superparamagnetic iron oxide: a feasibility study.
    Shiozawa M; Kobayashi S; Sato Y; Maeshima H; Hozumi Y; Lefor AT; Kurihara K; Sata N; Yasuda Y
    Breast Cancer; 2014 Jul; 21(4):394-401. PubMed ID: 22926506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoiding unnecessary sentinel lymph node biopsy with the use of superparamagnetic iron oxide mapping agents (Magtrace®) in breast surgery.
    Cui RBJ; Hawes S; Azimi F; Chan B; Graham S; Mak C; Seah JL; Warrier S
    ANZ J Surg; 2024 Jun; 94(6):1090-1095. PubMed ID: 38456358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative injection of radiocolloid for sentinel node biopsy in breast cancer.
    Vu HN; O'Connor PF; Shoemaker RR; Wan W; Fratkin MJ; Bear HD
    J Nucl Med Technol; 2013 Dec; 41(4):263-7. PubMed ID: 24231723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of immediate preoperative injection of radiopharmaceutical and blue dye for sentinel node biopsy in patients with breast cancer.
    Dixon JM; Mak C; Radhakrishna S; Kehoe T; Millar AM; Wong D; Thomas JS
    Eur J Cancer; 2009 Mar; 45(5):795-9. PubMed ID: 19101140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of low dose superparamagnetic iron oxide tracer for sentinel node biopsy in breast conserving treatment on susceptibility artefacts on magnetic resonance imaging and contrast enhanced mammography.
    van Haaren ERM; Spiekerman van Weezelenburg MA; van Bastelaar J; Janssen A; van Nijnatten T; Bouwman LH; Vissers YLJ; Lobbes MBI
    Surg Oncol; 2024 Apr; 53():102045. PubMed ID: 38330805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Turkish SentiMAG feasibility trial: preliminary results.
    Vural V; Yılmaz OC
    Breast Cancer; 2020 Mar; 27(2):261-265. PubMed ID: 31621053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative injection of subareolar or dermal radioisotope results in predictable identification of sentinel lymph nodes in breast cancer.
    Johnson CB; Boneti C; Korourian S; Adkins L; Klimberg VS
    Ann Surg; 2011 Oct; 254(4):612-8. PubMed ID: 21918427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.